会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明授权
    • Amino thiol peptides
    • 氨基硫醇肽
    • US4636560A
    • 1987-01-13
    • US672044
    • 1984-11-16
    • Jollie D. Godfrey, Jr.Eric M. GordonNorma G. Delaney
    • Jollie D. Godfrey, Jr.Eric M. GordonNorma G. Delaney
    • C07D521/00A61K31/16A61K31/165A61K31/195A61K31/215A61K31/22A61K38/00A61K38/55A61P25/04A61P43/00C07C67/00C07C313/00C07C323/25C07C323/26C07C323/29C07C323/44C07C323/58C07C323/60C07K5/04C07K5/06C07K5/065C07K5/072C07K5/083C07K5/09C07K5/103C07K7/06C07K14/81C07C149/273
    • C07K5/1008C07C323/44C07K5/06043C07K5/06078C07K5/06095C07K5/0804C07K5/0815A61K38/00Y10S530/80
    • Analgesic and hypotensive activity is exhibited by compounds having the formula ##STR1## and pharmaceutically acceptable salts thereof, wherein R.sub.1 and R.sub.2 are each independently hydrogen, alkyl, carboxyalkyl, halo substituted alkyl, hydroxyalkyl, aminoalkyl, mercaptoalkyl, alkylthioalkyl, (cycloalkyl)alkyl, (heteroaryl)alkyl, arylalkyl, carbamoylalkyl, guanidinylalkyl, or heteroaryl;R.sub.3 is hydroxy, alkoxy, (substituted alkyl)oxy, arylalkoxy, (heteroaryl)alkoxy, or --NY.sub.1 Y.sub.2, wherein Y.sub.1 and Y.sub.2 are each independently hydrogen, alkyl, aryl, or arylalkyl, or Y.sub.1 is hydrogen and Y.sub.2 is substituted alkyl or (heteroaryl)alkyl;A.sub.1 is glycyl, alanyl, leucyl, phenylalanyl, arginyl, sarcosyl, seryl, asparagyl, lysyl, glutamyl, histidyl, tryptophyl, cysteinyl, methionyl, threonyl, tyrosyl, leucyl, valyl, aspartyl, prolyl, norleucyl, norvalyl, or ##STR2## wherein n.sub.6 is an integer of 2 to 15; A.sub.2, A.sub.3, A.sub.4 and A.sub.5 each is independently glycyl, alanyl, leucyl, phenylalanyl, arginyl, sarcosyl, seryl, asparagyl, lysyl, glutamyl, histidyl, tryptophyl, cysteinyl, methionyl, threonyl, tyrosyl, leucyl, valyl, aspartyl, prolyl, norleucyl, or norvalyl; andn.sub.1, n.sub.2, n.sub.3, n.sub.4 and n.sub.5 each is independently 0 or 1.
    • 具有式(IMA)> TR(A1)n1(A2)n2(A3)n3(A4)n4(A5)n5R3的化合物及其药学上可接受的盐,其中R1和R2各自独立地表现出止痛和降血压活性 氢,烷基,羧基烷基,卤素取代的烷基,羟基烷基,氨基烷基,巯基烷基,烷硫基烷基,(环烷基)烷基,(杂芳基)烷基,芳基烷基,氨基甲酰基烷基,胍基烷基或杂芳基; R3是羟基,烷氧基,(取代的烷基)氧基,芳基烷氧基,(杂芳基)烷氧基或-NY1Y2,其中Y1和Y2各自独立地是氢,烷基,芳基或芳烷基,或Y1是氢,Y2是取代的烷基或( 杂芳基)烷基; A1是甘氨酰基,丙氨酰基,亮氨酰基,苯丙氨酰,精氨酰,肌氨酰,丝氨酰,天冬酰胺基,赖氨酰,谷氨酰,组氨酸,色氨酸,半胱氨酰,甲硫氨酰,苏氨酰,酪氨酰,亮氨酰,缬氨酰,天冬氨酰,脯氨酰, 其中n6为2至15的整数; A2,A3,A4和A5各自独立地为甘氨酰,丙氨酰,亮氨酰,苯丙氨酰,精氨酰,肌氨酰,丝氨酰,天冬酰胺酰基,赖氨酰,谷氨酰,组氨酰,色氨酰,半胱氨酰,甲硫氨酰,苏氨酰,酪氨酰,亮氨酰,缬氨酰,天冬氨酰, 正亮片或正戊基; n1,n2,n3,n4和n5各自独立地为0或1。
    • 16. 发明授权
    • Phenyl hydroxamic acids including a hetero-containing substituent
    • 苯基异羟肟酸,包括含杂原子的取代基
    • US4906667A
    • 1990-03-06
    • US203527
    • 1988-05-23
    • Ravi K. VarmaEric M. GordonMartin F. Haslanger
    • Ravi K. VarmaEric M. GordonMartin F. Haslanger
    • C07C259/10
    • C07C259/10C07C2101/04C07C2101/08C07C2101/14
    • Phenyl hydroxamic acids are disclosed having the general formula ##STR1## or a pharmaceutically acceptable salt thereof, wherein X is NR, oxygen, sulfur, ##STR2## or a single bond, and Y is NR, oxygen, sulfur, ##STR3## or a single bond, where R can be hydrogen or lower alkyl, g can be 1 or 2, and with the proviso that at least one of X and Y is other than a single bond; Z is aryl, aralkyl or cycloalkyl; R.sub.1 is hydrogen, substituted or unsubstituted lower alkyl, cycloalkyl, lower alkenyl or aryl; R.sub.2 is hydrogen, lower alkyl, aroyl or acyl; m is 0 to 4 carbon atoms; and, n is 0 to 4 carbon atoms further providing that if one of X or Y is oxygen, the other of X or Y must be oxygen and further that when X and Y are oxygen Z cannot be aralalkyl.These new compounds have been found to be inhibitors or arachidonic acid 5-lipoxygenase and are therefore useful as antiallergy agents and antipsoriatics.
    • 公开了具有通式为“IMAGE”或其药学上可接受的盐的苯基异羟肟酸,其中X是NR,氧,硫,或单键,Y是NR,氧,硫, 单键,其中R可以是氢或低级烷基,g可以是1或2,条件是X和Y中的至少一个不是单键; Z是芳基,芳烷基或环烷基; R 1是氢,取代或未取代的低级烷基,环烷基,低级烯基或芳基; R2是氢,低级烷基,芳酰基或酰基; m为0〜4个碳原子; 并且n为0至4个碳原子,条件是如果X或Y中的一个为氧,X或Y中的另一个必须为氧,此外,当X和Y为氧时,Z不能为芳烷基。 已经发现这些新化合物是抑制剂或花生四烯酸5-脂氧合酶,因此可用作抗过敏剂和抗牛皮癣剂。